Loading…
Risk factors for radiation‐induced optic neuropathy: a case–control study
Importance Identifying risk factors for radiation‐induced optic neuropathy (RION) could promote a more conservative approach to radiation treatment planning in vulnerable patients. Background This study explored possible factors beyond radiation dose associated with the development of RION after ext...
Saved in:
Published in: | Clinical & experimental ophthalmology 2017-08, Vol.45 (6), p.592-597 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Importance
Identifying risk factors for radiation‐induced optic neuropathy (RION) could promote a more conservative approach to radiation treatment planning in vulnerable patients.
Background
This study explored possible factors beyond radiation dose associated with the development of RION after external beam radiation therapy.
Design
This was a retrospective case–control study conducted at a university hospital tertiary care center.
Participants
Cases (n = 14) meeting criteria for a diagnosis of RION by neuro‐ophthalmologic exam were identified from a single‐centre neuro‐ophthalmology database. Controls (n = 31) without RION were selected from a single‐centre radiation oncology database.
Methods
Controls were matched to cases based upon maximum radiation dose to the optic apparatus. Patient characteristics and treatment parameters were interrogated by univariate analysis for attributes predisposing to RION.
Main Outcome Measures
The primary parameter was a significant association of patient characteristics or treatment parameters with RION.
Results
Controlling for radiation dosage, no significant associations for alternative risk factors were identified.
Conclusions and Relevance
These results support the literature suggesting that the primary risk factor for developing RION is radiation dosage and that additional patient‐related and tumour‐related risk factors may play only a minor role. |
---|---|
ISSN: | 1442-6404 1442-9071 |
DOI: | 10.1111/ceo.12927 |